Evidence map›Paper›PMID 22890762›Full record

ArticleAntimicrobial agents and chemotherapy2012

Macrolides and β-lactam antibiotics enhance C3b deposition on the surface of multidrug-resistant Streptococcus pneumoniae strains by a LytA autolysin-dependent mechanism.

Elisa Ramos-Sevillano, Cinthya Rodríguez-Sosa, Roberto Díez-Martínez, María-José Giménez, Eduardo Olmedillas, Pedro García, Ernesto García, Lorenzo Aguilar, Jose Yuste

Open access · bronzeAbstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.8field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 16 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Role ofFrontiers in microbiology · 2017
    Review
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 1 country.

Elisa Ramos-SevillanoCentro de Investigaciones Biológicas (CSIC) and CIBER de Enfermedades Respiratorias (CIBERES), Madrid, Spain.
Cinthya Rodríguez-Sosa
Roberto Díez-Martínez
María-José Giménez
Eduardo Olmedillas
Pedro García
Ernesto García
Lorenzo Aguilar
Jose Yuste
Centro de Investigación Biomédica en Red de Enfermedades Respiratorias · ESCentro de Investigaciones Biológicas Margarita Salas · ESInstituto de Salud Carlos III · ESUniversidad Complutense de Madrid · ESCentro Nacional de Microbiologia · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The emergence of Streptococcus pneumoniae strains displaying high levels of multidrug resistance is of great concern worldwide and a serious threat for the outcome of the infection. Modifications of the bacterial envelope by antibiotics may assist the recognition and clearance of the pathogen by the host immune system. Recognition of S. pneumoniae resistant strains by the complement component C3b was increased in the presence of specific anti-pneumococcal antibodies and subinhibitory concentrations of different macrolides and β-lactam antibiotics for all the strains investigated. However, C3b levels were unchanged in the presence of serum containing specific antibodies and sub-MICs of levofloxacin. To investigate whether LytA, the main cell wall hydrolase of S. pneumoniae, might be involved in this process, lytA-deficient mutants were constructed. In the presence of antibiotics, loss of LytA was not associated with enhanced C3b deposition on the pneumococcal surface, which confirms the importance of LytA in this interaction. The results of this study offer new insights into the development of novel therapeutic strategies using certain antibiotics by increasing the efficacy of the host immune response to efficiently recognize pneumococcal resistant strains.

Indexed as

AnimalsAnti-Bacterial AgentsBacterial Proteinsbeta-LactamsCell WallComplement C3bCulture MediaDrug Resistance, Multiple, BacterialImmune SeraMacrolidesMiceMice, Inbred BALB CMicrobial Sensitivity TestsMutationN-Acetylmuramoyl-L-alanine AmidaseStreptococcus pneumoniaeAnti-Bacterial AgentsBacterial Proteinsbeta-LactamsComplement C3bCulture MediaImmune SeraMacrolidesN-Acetylmuramoyl-L-alanine Amidase

Identifiers

PMID22890762
PMCPMC3486588
OpenAlexW1976429328

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.